ERA - Leading European Nephrology

My ERA Join ERA

Home | Video pages | Webcast | The impact of novel anticancer therapies on blood pressure and kidney function in patients with CKD

The impact of novel anticancer therapies on blood pressure and kidney function in patients with CKD

Share

https://www.youtube.com/watch?v=pEw5i17BSjY copy

Other e-seminars from EuReCa-M

Webcast

Thyroid Hormone in CKD patients with diabetes: what is known, what is new

Webcast

Long-term cardiovascular complications following AKI

Webcast

What does the Cardiovascular-Kidney-Metabolic (CKM) Syndrome mean for nephrologists?

EuReCa-M WG

Webcast

SGLT2 inhibitors and haemoglobin increase: a possible explanation of the cardiovascular benefits?

EuReCa-M WG

Webcast

Heart failure in patients with CKD: diagnosis and therapeutic approaches

EuReCa-M WG

Webcast

Calcification propensity: from biomarker to treatment target?

Webcast

Assessment and management of hypertension in dialysis patients

Webcast

GLP-1 receptor agonists in patients with CKD not on dialysis; beyond cardiorenal protection

Webcast

Echocardiography or Cardiac Magnetic resonance Imaging (or both) for cardiac assessment in CKD patients?

EuReCa-M WG

Webcast

Physical Activity in CKD patients: time to overcome nephrologist’s inertia

EuReCa-M WG

Webcast

Let´s talk about sex: disparities in the outcomes and quality of care of men and women with kidney disease

EuReCa-M WG